Australian regulations require that peptide products for therapeutic use carry an ARTG (Australian Register of Therapeutic Goods) number, with 78% of verified GHK-Cu products meeting this criterion as of 2024
It achieves this by modulating various inflammatory cytokines and growth factors, creating a more conducive environment for healing and minimizing the factors that contribute to abnormal scar formation
- Bo qun sn phm ni thong mt, trnh lu tr nhit d cao, trnh xa tm tay ca tr em
BPC-157 (Body Protection Compound-157) is a 15-amino-acid gastric peptide studied for accelerating musculoskeletal healing by upregulating growth factor signaling [3] [4]
Although the overall evidence suggests that at least a subset of patients with ME/CFS exhibit reduced cortisol output, some cohorts show only modest reductions, preserved cortisol output, or context-dependent abnormalities rather than stable hypocortisolism, indicating that HPA-axis dysfunction in ME/CFS is likely heterogeneous and multifactorial rather than a specific or uniform neuroendocrine abnormality (Cleare, 2003
